De Novo Design of Mirror-Image Dimeric Antimicrobial Peptides with Low Drug Resistance and In Vivo Efficacy
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.5c01375 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Jingying Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutics, School of Pharmacy, 2019RU066, Lanzhou University, Lanzhou 730000, P. R. China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Antimicrobial Cationic Peptides, Antimicrobial Peptides, Drug Design. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences, Lanzhou University, Program for Changjiang Scholars and Innovative Research Team in University.
Abstract (Originalsprache)
Dimerization and mirror-image modification are effective strategies for enhancing the antimicrobial activity and stability of antimicrobial peptides (AMPs). However, mirror-image dimeric AMPs, characterized by their mirror-image amino acid sequences and mirror-image stereocenters within a single peptide, have been rarely reported. In this study, 19 mirror-image dimeric AMPs and 2 all d-/l-type AMPs are designed and synthesized to investigate their structure–activity relationships. Peptides with YYYXXxxyyy or yyyxxXXYYY sequences (X/Y represents cationic/hydrophobic residues, x/y denotes d-type residues) possess favorable bacterial selectivity. The superior peptide M-WL-D/L exhibits potent activity against multidrug-resistant bacteria, a low propensity for drug resistance, favorable stability, robust membrane disruption, high DNA affinity, and immunoregulatory activity. Notably, M-WL-D/L demonstrates in vivo half-lives of 22.4 min (5 mg/kg) and 20.7 min (10 mg/kg), along with effective in vivo efficacy and satisfactory safety. This innovative AMP design strategy, with M-WL-D/L as a standout candidate, offers a promising avenue for combating multidrug-resistant bacteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Pharmaceutics, School of Pharmacy, 2019RU066, Lanzhou University, Lanzhou 730000, P. R. China.
- State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macao 999078, China.
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou 510632, P. R. China.
ORCID-Profile: Yun Zhang, Jingman Ni
Förderung
- Chinese Academy of Medical Sciences
- Lanzhou University
- Program for Changjiang Scholars and Innovative Research Team in University
- National Natural Science Foundation of China
- Natural Science Foundation of Gansu Province
Zitieren
APA
Zhang, J., Chu, A., Yang, P., Ouyang, X., Li, B., Mao, W., Wu, X., Zhong, C., Gou, S., Zhang, Y., Liu, H., & Ni, J. (2025). De Novo Design of Mirror-Image Dimeric Antimicrobial Peptides with Low Drug Resistance and In Vivo Efficacy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c01375
Vancouver
Zhang J, Chu A, Yang P, Ouyang X, Li B, Mao W, et al. De Novo Design of Mirror-Image Dimeric Antimicrobial Peptides with Low Drug Resistance and In Vivo Efficacy. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c01375
BibTeX
@article{Zhang2025,
author = {Zhang, Jingying and Chu, Anqi and Yang, Ping and Ouyang, Xu and Li, Beibei and Mao, Wenbo and Wu, Xiaoyan and Zhong, Chao and Gou, Sanhu and Zhang, Yun and Liu, Hui and Ni, Jingman},
title = {De Novo Design of Mirror-Image Dimeric Antimicrobial Peptides with Low Drug Resistance and In Vivo Efficacy},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.5c01375}
}
EUVIMED